journal article·2006-07

Standardization criteria for an ischemic surgical model of acute hepatic failure in pigs

Martin Nieuwoudt, Richarda Kunnike, Mario Smuts, Johan Becker, G. Frik Stegmann, Christelle Van der Walt, Johan Neser, Schalk Van der Merwe

Biomaterials· Volume 27· Issue 20
Publisher page

Abstract

The establishment of a reliable large animal model of acute hepatic failure (AHF) is critical for the evaluation of supportive therapies such as bioartificial liver support systems (BALSS). Large animal surgical models bear some resemblance to the clinical syndrome of AHF in humans. However, these are inherently complex and are predisposed to inter-individual variation. The development of considerable skill is required and no precise standardization criteria for such models have been defined as yet. This study investigates a surgically induced ischemic model of AHF in 15 female Landrace pigs. A large set of systemic and biochemical variables were measured. The absolute values of systemic variables during the surgery and the rates of change of the biochemical variables following the surgery were correlated with the duration of survival of each animal. A multivariate prognosis was revealed, with several variables simultaneously determining survival. Those of importance in the surgical period included the duration of portal occlusion, the pulse rate during this time, the total blood lost, the mean arterial pressure and the body temperature after the procedure. In the post-surgical period the rates of change of blood ammonia, branch chain amino acids, haemoglobin, hematocrit, body temperature, total urinary excretion and mean blood pH all demonstrated some importance to survival. Based on the above and clinical experience, standardization criteria specific for this model were defined. Additional variables that posses value in AHF but demonstrate lower correlations with survival were also included, e.g. the prothrombin time, clotting factors, liver enzymes, potassium, bilirubin, creatinine and lactate. Valuable procedural information was generated, which stabilized the model, limited unnecessary blood sampling and cut laboratory costs. The criteria allow the early exclusion of compromized animals and the identification of those demonstrating characteristics predictive of longer survival prior to BALSS connection. This is likely to allow more accurate comparisons between small treatment and control groups. In effect, the above are the converse of the King's college criteria (for humans) as they are designed to exclude animals with prognoses that are insufficiently bleak or due to factors other than AHF. The statistical analysis employed also identified the variables that in future may allow the evaluation of prognosis in real-time.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Liver Disease and Transplantation · Organ Transplantation Techniques and Outcomes · Liver Disease Diagnosis and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (19)

Show source-provided references
1. Galactosamine induced fulminant hepatic failure10.1002/hep.510260544 ↗
2. An improved model of galactosamine induced fulminant hepatic failure in the pig10.1006/jsre.1998.5420 ↗
3. Acetaminophen induced fulminant hepatic failure in pigs: A new model to assess pre-clinical liver assistance (Abstract)
4. Acetominophen induced acute hepatic failure in pigs: controversial results to other animals10.1007/BF01852004 ↗
5. The anhepatic model in a pig
6. Assessment of the AMC-Bioartificial liver in the anhepatic pig10.1097/00007890-200201270-00009 ↗
7. An improved model of acute liver failure based on transient ischemia of the liver10.1001/archsurg.135.10.1183 ↗
8. Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver10.1177/039139889902201008 ↗
9. An experimental large animal model for the assessment of bioartificial liver support systems in fulminant hepatic failure10.1080/003655202320378293 ↗
10. Animal models of fulminant hepatic failure: A critical evaluation
11. Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research10.1016/S0142-9612(03)00509-X ↗
12. Animal models of fulminant hepatic failure10.1007/BF01311235 ↗
13. Early indicators of prognosis in fulminant hepatic failure10.1016/0016-5085(89)90081-4 ↗
14. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria10.1016/S0168-8278(97)80010-4 ↗
15. Animal models of acute hepatic failure10.1046/j.1365-2613.2000.00144.x ↗
16. Animal models of hepatic encephalopathy
17. Complications of intracranial pressure monitoring in fulminant hepatic failure10.1016/0140-6736(93)90016-A ↗
18. Fischer JE, Baldessarini RJ. Pathogensis and therapy of hepatic coma. Progress in liver disease. 1976; p. 363–97 [Chapter 23].
19. Acute hepatic ischemia in the pig: changes in plasma hormones, amino acids and brain chemistry